Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2021 ADA 糖尿病医学诊疗标准

2020-12-09 美国糖尿病学会 Diabetes Care.2021 Jan;44(Suppl 1):S1-S232.

糖尿病

ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一，每年都会对该指南进行更新和修改。2021年美国糖尿病学会(ADA)糖尿病医学诊疗标准发布，共包括16部分内容。

中文标题：

2021 ADA 糖尿病医学诊疗标准

英文标题：

Standards of Medical Care in Diabetes—2021

发布机构：

美国糖尿病学会

发布日期：

2020-12-09

简要介绍：

ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一，每年都会对该指南进行更新和修改。2021年美国糖尿病学会(ADA)糖尿病医学诊疗标准发布，共包括16部分内容。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ADA 糖尿病医学诊疗标准.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d40f41c0020238da, title=2021 ADA 糖尿病医学诊疗标准, enTitle=Standards of Medical Care in Diabetes—2021, guiderFrom=Diabetes Care.2021 Jan;44(Suppl 1):S1-S232., authorId=0, author=, summary=ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一，每年都会对该指南进行更新和修改。2021年美国糖尿病学会(ADA)糖尿病医学诊疗标准发布，共包括16部分内容。, cover=https://img.medsci.cn/20201213/1607840061940_2020535.jpg, journalId=0, articlesId=null, associationId=54, associationName=美国糖尿病学会, associationIntro=美国糖尿病协会县美国重要的非赢利性卫生姐织，旨在提供有关糖尿病的研究进展和信息，促进糖尿病的科研、教育、诊疗等，关注一切与糖尿病有关的事务。协会成立千 1940年，以预防和治疗糖尿病，改善所有糖尿病患者生活质量为目标。一年一度的全球糖尿病领域最大规模的盛会&mdash;&mdash;美国糖尿病协会（ADA)年会于每年的6月如期而至，每年将有来自世界各地的13000名研究者、医生及其他专业人士莅临，共同分享糖尿病领域前沿研究、治疗建议以及治疗新趋势，聚焦糖尿病领域基础研究与临床实践的最新进展，公布最新临床试验结果，关注如何将研究成果应用于临床实践。, copyright=0, guiderPublishedTime=Wed Dec 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一，每年都会对该指南进行更新和修改。2021年美国糖尿病学会(ADA)糖尿病医学诊疗标准发布，共包括16部分内容。</span></p> </div> </div> </div>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=32791, appHits=2260, showAppHits=0, pcHits=4959, showPcHits=30527, likes=18, shares=171, comments=165, approvalStatus=1, publishedTime=Sun Dec 13 14:24:42 CST 2020, publishedTimeString=2020-12-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 13 14:14:31 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:55:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ADA 糖尿病医学诊疗标准.pdf)])
2021 ADA 糖尿病医学诊疗标准.pdf
下载请点击：
评论区 (131)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193654, encodeId=969a119365489, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:13:14 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082176, encodeId=6dd110821e6f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75302344449, createdName=1229a05dm15暂无昵称, createdTime=Mon Dec 20 18:26:29 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079706, encodeId=ef1a10e970658, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8795679309, createdName=123dk1, createdTime=Mon Dec 13 21:38:55 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069503, encodeId=37e41069503ee, content=谢谢分享 太实用啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211012/5dc0b753a39f48d1a34b9d4a9608e5ea/c8133b8a074b4de098a3341336530e89.jpg, createdBy=ee135632679, createdName=向教员学习, createdTime=Fri Nov 12 09:45:45 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062924, encodeId=a53e10629241e, content=正好要学习，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01c5209406, createdName=14757fdfm46暂无昵称, createdTime=Fri Oct 22 13:47:10 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2022-02-15 Daniel1218

    感谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193654, encodeId=969a119365489, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:13:14 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082176, encodeId=6dd110821e6f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75302344449, createdName=1229a05dm15暂无昵称, createdTime=Mon Dec 20 18:26:29 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079706, encodeId=ef1a10e970658, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8795679309, createdName=123dk1, createdTime=Mon Dec 13 21:38:55 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069503, encodeId=37e41069503ee, content=谢谢分享 太实用啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211012/5dc0b753a39f48d1a34b9d4a9608e5ea/c8133b8a074b4de098a3341336530e89.jpg, createdBy=ee135632679, createdName=向教员学习, createdTime=Fri Nov 12 09:45:45 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062924, encodeId=a53e10629241e, content=正好要学习，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01c5209406, createdName=14757fdfm46暂无昵称, createdTime=Fri Oct 22 13:47:10 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-12-20 1229a05dm15暂无昵称

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193654, encodeId=969a119365489, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:13:14 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082176, encodeId=6dd110821e6f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75302344449, createdName=1229a05dm15暂无昵称, createdTime=Mon Dec 20 18:26:29 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079706, encodeId=ef1a10e970658, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8795679309, createdName=123dk1, createdTime=Mon Dec 13 21:38:55 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069503, encodeId=37e41069503ee, content=谢谢分享 太实用啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211012/5dc0b753a39f48d1a34b9d4a9608e5ea/c8133b8a074b4de098a3341336530e89.jpg, createdBy=ee135632679, createdName=向教员学习, createdTime=Fri Nov 12 09:45:45 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062924, encodeId=a53e10629241e, content=正好要学习，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01c5209406, createdName=14757fdfm46暂无昵称, createdTime=Fri Oct 22 13:47:10 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-12-13 123dk1

    谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1193654, encodeId=969a119365489, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:13:14 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082176, encodeId=6dd110821e6f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75302344449, createdName=1229a05dm15暂无昵称, createdTime=Mon Dec 20 18:26:29 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079706, encodeId=ef1a10e970658, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8795679309, createdName=123dk1, createdTime=Mon Dec 13 21:38:55 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069503, encodeId=37e41069503ee, content=谢谢分享 太实用啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211012/5dc0b753a39f48d1a34b9d4a9608e5ea/c8133b8a074b4de098a3341336530e89.jpg, createdBy=ee135632679, createdName=向教员学习, createdTime=Fri Nov 12 09:45:45 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062924, encodeId=a53e10629241e, content=正好要学习，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01c5209406, createdName=14757fdfm46暂无昵称, createdTime=Fri Oct 22 13:47:10 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-11-12 向教员学习

    谢谢分享 太实用啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1193654, encodeId=969a119365489, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erlX38CDvSA1q72mjq80oVpTmmQIRLoQVYvpTMIXCAicm0Tnia7lvkyEGy8abdDK7I3123CCLMpbRdA/132, createdBy=746466613, createdName=Daniel1218, createdTime=Tue Feb 15 17:13:14 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082176, encodeId=6dd110821e6f1, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75302344449, createdName=1229a05dm15暂无昵称, createdTime=Mon Dec 20 18:26:29 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079706, encodeId=ef1a10e970658, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d8795679309, createdName=123dk1, createdTime=Mon Dec 13 21:38:55 CST 2021, time=2021-12-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069503, encodeId=37e41069503ee, content=谢谢分享 太实用啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211012/5dc0b753a39f48d1a34b9d4a9608e5ea/c8133b8a074b4de098a3341336530e89.jpg, createdBy=ee135632679, createdName=向教员学习, createdTime=Fri Nov 12 09:45:45 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062924, encodeId=a53e10629241e, content=正好要学习，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01c5209406, createdName=14757fdfm46暂无昵称, createdTime=Fri Oct 22 13:47:10 CST 2021, time=2021-10-22, status=1, ipAttribution=)]
    2021-10-22 14757fdfm46暂无昵称

    正好要学习，谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中药新药用于糖尿病肾脏疾病临床研究技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2019-05-30

中药新药用于糖尿病足病临床研究技术指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2019-05-23

关于成人2型糖尿病/糖尿病前期治疗的伊拉克专家共识

暂未更新 · 2020-08-05

2020 国际专家组共识：成人隐匿性自身免疫性糖尿病的管理

国外内分泌相关专家小组（统称） · 2020-08-26

成人迟发性自身免疫糖尿病管理：一个国际专家组共识

暂未更新 · 2020-08-02

2020 AMD/SID/SIEDP共识声明：糖尿病酮症酸中毒

国外内分泌相关专家小组（统称） · 2020-06-20

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01

Baidu
map
Baidu
map
Baidu
map